Lobbying client

EMALEX

Biotechnology research and development

Filings
1
Filed by
1
Reported in-house
—
Reported by firms
—

Filings

1 filing, newest first.
Filing Filed by Amount
Registration
2nd Quarter 2025
JK STRATEGIES, PUBLIC AFFAIRS ,LLC — reported

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.